Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;73(3):209-212.
doi: 10.5455/medarh.2019.73.209-212.

Clinical Characteristics and Outcome of Malignant Eyelid Tumors: A Five-Year Retrospective Study

Mufid Burgic  1 , Ermina Iljazovic  2 , Amra Nadarevic Vodencarevic  3 , Musfaha Burgic  1 , Adi Rifatbegovic  1 , Amer Mujkanovic  1 , Meliha Halilbasic  4 , Mersiha Sinanovic  4
Affiliations

Clinical Characteristics and Outcome of Malignant Eyelid Tumors: A Five-Year Retrospective Study

Mufid Burgic et al. Med Arch. 2019 Jun.

Abstract

Introduction: To the best of our knowledge, this is the first study about malignant eyelid tumors in the region of Tuzla, Bosnia and Herzegovina, and it shows similar results comparing with other countries (the annual incidence of eyelid tumors in Tuzla region is about 3.73/100 000 population). Malignant eyelid tumors are relatively uncommon, but potentially fatal disease. However, if detected early and treated adequately, the prognosis is generally excellent.

Aim: The aim of this study was the clinical and microscopical analysis of malignant eyelid tumors in treated patients, the presentation of surgical treatment and reconstructive methods of eyelid tumors.

Methods: This retrospective study included 60 patients surgically treated at the University Clinical Center Tuzla from January 2012 to December 2016, who were initially diagnosed with malignant eyelid tumors in accordance to the final results obtained by histological examination of excised lesions.

Results: In the group of malignant tumors, the most common tumors were BCC (85%), which were predominantly found on the lower eyelids (92.16%) and showed female predominance (51.06%). SCC was the second most common eyelid malignancy (15%) and showed a predilection for the lower eyelid involvement and male predominance (55.56%). Tumors up to 2 cm in diameter (clinical stage T1) were found in 78.33% of cases, 95.74% of which with radical excision, while 4.26% with non-radical excision.

Conclusion: Treatment by complete excision with histological confirmation of tumor clearance is recommended. Perineural spread is an adverse prognostic sign, which may require postoperative radiotherapy. Orbital invasion is a rare complication but, if recognized early, it can be treated effectively with exenteration. Because presentation varies and histological examination is required for accurate diagnosis, any suspicious lesion occurring on the eyelids should be excised or biopsied. All patients with malignant tumors should be advised of the risk of recurrent or new tumors and encouraged to attend lifelong follow up.

Keywords: Malignant Eyelid tumors; clearance; histological confirmation; tumor excision.

PubMed Disclaimer

Figures

Graph 1.
Graph 1.. Distributions of malignant eyelid tumors in Tuzla region from 2012 to 2016
Graph 2.
Graph 2.. Correlation between size of tumors and excision radicality
Figure 1.
Figure 1.. BCC of upper and lower eyelid
Figure 2.
Figure 2.. Postoperative result
Figure 3 and 4.
Figure 3 and 4.. Radically excised BCC with reconstructive procedure planned
See this image and copyright information in PMC

References

    1. Lo JS, Snow SN, Reizner GT. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991;24(5):715–719. - PubMed
    1. Kyrgidis A, Vahtsevanos K, Tzellos TG. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital. Euro J Dermatol. 2010;20(3):276–282. - PubMed
    1. Sun MT, Wu A, Huilgol SC, Selva D. Accuracy of biopsy in subtyping periocular basal cell carcinoma. Ophthal Plast Reconstr Surg. 2015;31(6):449–451. - PubMed
    1. Chren MM, Linos E, Torres JS. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2013;133(5):1188–1196. - PMC - PubMed
    1. Silverman MK, Kopf AW, Bart RS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol. 1992;18(6):471–476. - PubMed